Review decision: 

This guideline will shortly be checked to see if it needs updating, please register as a stakeholder to be informed about the decision.

Register as a stakeholder

Next review date: March 2016

Recommendations 1.1.2 to 1.1.5 have been replaced by NICE guideline NG12 (published June 2015).

This guidance updates and replaces NICE guideline CG24 (published February 2005).

It offers evidence-based advice on the care and treatment of people with lung cancer. New and updated recommendations are included on communication, diagnosis and staging, selection of patients with non-small-cell lung cancer (NSCLC) for treatment with curative intent, surgery with curative intent for NSCLC, smoking cessation, combination treatment for NSCLC, treatment for small-cell lung cancer (SCLC), managing endobronchial obstruction, managing brain metastases, and follow-up and patient perspectives.

  • National Institute for Health and Care Excellence (NICE) accreditation logo